Average Co-Inventor Count = 3.49
ph-index = 32
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Diabetes Care Inc. (212 from 1,329 patents)
2. Therasense, Inc. (11 from 53 patents)
3. Abbott Point of Care Inc. (3 from 235 patents)
4. Other (1 from 831,952 patents)
5. E. Heller & Company (1 from 19 patents)
6. Abbott Diabates Care Inc. (1 from 2 patents)
7. Abbott Diabetes Inc. (1 from 1 patent)
230 patents:
1. 12404535 - NAD(P) depot for NAD(P)-dependent enzyme-based sensors
2. 12396666 - Analyte sensing devices and methods
3. 12398413 - NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
4. 12390562 - Antimicrobial and microstatic sensor systems
5. 12385077 - NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
6. 12345671 - Analyte sensors for detecting asparagine and aspartate and methods of use thereof
7. 12326441 - Method and apparatus for providing data processing and control in a medical communication system
8. 12313622 - Method and apparatus for providing data processing and control in a medical communication system
9. 12290355 - Continuous potassium sensors and methods of use thereof
10. 12290359 - Sensor array systems and methods for detecting multiple analytes
11. 12268496 - Systems, devices and methods for analyte sensor insertion
12. 12268500 - Transcutaneous sensor with dual electrodes and methods of detecting and compensating for withdrawal of a transcutaneous sensor from a patient
13. 12239442 - Analyte sensors with reduced interferent signal and methods
14. 12234498 - NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
15. 12220235 - Analyte sensors and sensing methods for dual detection of glucose and ethanol